Riot Platforms Options Volume Surges
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 27 2026
0mins
Should l Buy OSCR?
Source: NASDAQ.COM
- Surge in Options Volume: Riot Platforms Inc has seen options trading volume reach 124,196 contracts today, equating to approximately 12.4 million shares, indicating a trading activity level of 71.4% of its average daily volume over the past month.
- High-Frequency Trading Insight: Notably, the $14 strike put option expiring on March 27, 2026, has recorded a trading volume of 10,492 contracts today, representing about 1.0 million shares, reflecting market interest at this price point.
- NextNav Options Performance: NextNav Inc's options trading volume stands at 10,570 contracts, approximately 1.1 million shares, which constitutes 69.5% of its average daily trading volume over the past month, indicating rising market participation.
- Market Trend Observation: Particularly, the $19 strike call option expiring on June 18, 2026, has seen a trading volume of 2,509 contracts today, representing around 250,900 shares, suggesting investor expectations for future price increases.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy OSCR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on OSCR
Wall Street analysts forecast OSCR stock price to fall
8 Analyst Rating
1 Buy
4 Hold
3 Sell
Hold
Current: 20.870
Low
11.00
Averages
15.75
High
25.00
Current: 20.870
Low
11.00
Averages
15.75
High
25.00
About OSCR
Oscar Health, Inc. is a healthcare technology company built around a full stack technology platform. The Company's offerings include its insurance business and +Oscar Platform. Its health plans are offered in the individual market. The individual market primarily consists of policies purchased by individuals and families through health insurance marketplaces, established by the ACA and operated by the federal government, as well as other marketplaces operated by individual states. Individuals and families may also purchase policies in the individual market off-exchange. Employees whose employers have chosen to offer an Individual Coverage Health Reimbursement Arrangement (ICHRA) are also able to purchase its health plans. It offers health plans in the individual market under the five metal plan categories defined by the ACA: Catastrophic, Bronze, Silver, Gold, and Platinum. Through the +Oscar platform, the Company deploys its technology to help others throughout the healthcare system.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Barclays Raises Price Target: Barclays has increased its price target for Oscar Health from $18 to $21.
- Market Implications: This adjustment reflects Barclays' positive outlook on Oscar Health's performance in the market.
See More
- Tech Stocks Rally: The Nasdaq 100 surged 2.08% to reach an all-time high on Wednesday, driven by stellar earnings from chipmakers and AI infrastructure firms, particularly Advanced Micro Devices, which rose over 17% as it raised its full-year sales forecast, reflecting strong investor optimism about ongoing AI investments.
- Crude Oil Plunge: WTI crude oil prices fell more than 7% to a two-week low as market expectations for a US-Iran peace agreement increased, easing inflation fears and contributing to stock market gains, with the 10-year Treasury yield dropping to a one-week low of 4.33%.
- Employment Data Impact: The April ADP employment report indicated that US companies added 109,000 jobs, below the expected 120,000, yet the market remains optimistic about the Fed's monetary policy, believing it will help maintain a low interest rate environment.
- International Market Surge: Overseas stock markets closed sharply higher, with the Euro Stoxx 50 rising 2.68% and China's Shanghai Composite gaining 1.17%, indicating a positive global market response to the US economic recovery, further boosting investor confidence.
See More
- Strong Performance in Health Care Stocks: Late Wednesday afternoon, health care stocks were broadly higher, reflecting market optimism about the health sector, likely driven by investor expectations for future growth in healthcare demand.
- NYSE Health Care Index Increase: The rise in the NYSE Health Care Index indicates increased investor confidence in the healthcare sector, which may attract more capital into the field, thereby enhancing overall market performance.
- Market Trend Analysis: The upward trend in the healthcare sector may be linked to recent policy changes and technological innovations, with investor positive reactions potentially further driving stock prices higher.
- Improved Investor Sentiment: As health care stocks rise, investor sentiment has improved, which may lead to increased capital inflow into healthcare stocks, further propelling industry growth and development.
See More
- Tech Stock Rally: The Nasdaq 100 index surged over 1.44% to reach an all-time high, driven by strong earnings from chipmakers and AI infrastructure stocks, reflecting market optimism about sustained investment growth in artificial intelligence.
- Crude Oil Plunge: WTI crude oil prices fell more than 6% to a two-week low as the US nears a peace agreement with Iran, which is expected to lift restrictions on the Strait of Hormuz, thereby reducing energy costs and enhancing profitability prospects for airlines and cruise lines.
- Employment Data Impact: The April ADP employment change report indicated that US companies added 109,000 jobs, below the expected 120,000, yet the market remains optimistic about the Fed's monetary policy, suggesting a lower likelihood of interest rate hikes.
- Earnings Optimism: So far, 84% of the 375 S&P 500 companies that reported earnings have exceeded expectations, with Q1 earnings projected to rise 12% year-over-year, indicating strong corporate profitability that further supports the stock market's upward trend.
See More
- Market Performance: The S&P 500 index rose by 0.76% and the Nasdaq 100 index increased by 1.19%, reaching all-time highs, reflecting strong market optimism regarding ongoing investments in artificial intelligence, which are expected to continue driving stock prices higher.
- Chipmakers' Strong Earnings: Advanced Micro Devices (AMD) saw its stock price surge over 16% after raising its full-year sales forecast significantly due to robust data center spending, indicating a strong growth trajectory and reinforcing its competitive position in the semiconductor market.
- Crude Oil Price Plunge: WTI crude oil prices fell more than 5% to a two-week low as the US nears a peace agreement with Iran, which may help lower inflation expectations and improve profitability prospects for airlines and cruise operators amid declining fuel costs.
- Employment Data Impact: The April ADP employment change report indicated that US companies added 109,000 jobs, below the expected 120,000, yet the market remains optimistic about the Fed's monetary policy, which is likely to continue supporting stock market gains.
See More
- Strong Earnings Report: Oscar Health exceeded market expectations for Q1 2026 earnings, reporting $4.7 billion in revenue, which fell short of estimates by $270 million, yet achieved a robust 53% year-over-year growth driven by membership and rate increases.
- Decline in Medical Expenses: The medical loss ratio improved from 75.4% in the prior year to 70.5%, primarily due to the company's pricing strategy, which enhances profitability and strengthens competitive positioning in the market.
- Significant EBITDA Growth: The company reported an adjusted EBITDA of $721.1 million, reflecting over a 120% year-over-year increase and surpassing analyst projections of $435.7 million, indicating a notable improvement in operational efficiency.
- Full-Year Guidance Reaffirmed: Oscar Health reiterated its full-year 2026 outlook, forecasting a medical loss ratio between 82.4%-83.4% and revenue between $18.7 billion and $19.0 billion, with CEO Mark Bertolini emphasizing the company's commitment to significantly expanding margins and achieving meaningful profitability.
See More











